Role of Maharishi Amrit Kalash, Ayurvedic herbal medicine on Breast Cancer
- Conditions
- Health Condition 1: null- Breast Cancer
- Registration Number
- CTRI/2019/02/017775
- Lead Sponsor
- Maharishi Ayurveda Products Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients who are willing to participate in the study.
2. Women between age18 and 70 years, with histopathologically confirmed breast carcinoma of maximum diameter equal to 2.1 cm or above in whom neoadjuvant chemotherapy is planned.
3.Patients with skin involvement with fixed nodal metastasis will also be included.
4.Patients signed written informed consent.
5.Patients with normal liver and renal function test and normal ECG and echocardiogram.
1. Patients unwilling to participate.
2. Pregnant and lactating women.
3. Patients with concomitant severe heart, liver or renal diseases.
4. Patients with type one diabetes or uncontrolled type two diabetes with complications and/or on Insulin.
5.Patients deemed unfit to received chemotherapy due to poor general health
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete regression of tumor (clinical and pathological) in patients with breast cancer during neo-adjuvant chemotherapy.Timepoint: Clinical regression at each chemotherapy cycle <br/ ><br>(3 weekly) intervals. <br/ ><br>Pathological regression after surgery (app 6 months). <br/ ><br>
- Secondary Outcome Measures
Name Time Method Reduction of chemo toxicity in patients with breast cancer.Timepoint: After each chemotherapy cycle